Substrate
finance

Capital One Reports First-Quarter Profit, Missing Wall Street Estimates

Capital One, the largest U.S. credit-card lender, disclosed a first-quarter profit for 2026 that fell short of Wall Street expectations. The company also increased reserves for soured loans during the period. This comes amid ongoing economic monitoring in the financial sector.

BU
1 source·Apr 21, 8:46 PM(14 days ago)·1m read
Capital One Reports First-Quarter Profit, Missing Wall Street Estimatesunder30ceo.com
Audio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.

Capital One reported a first-quarter profit in 2026 that missed Wall Street estimates, according to @business. S. credit-card lender, increased reserves for potential loan losses as part of standard risk management, as stated by Capital One.

Provider in this area. The increase in provisions for loan losses occurred during the same quarter, reflecting precautionary measures by the lender, per Capital One's disclosure.

Key Facts

Profit Miss
Capital One's first-quarter profit in 2026 missed Wall Street estimates.
Loan Provisions
Capital One set aside more cash to cover soured loans in Q1 2026.
Market Position
Capital One is the biggest U.S. credit-card lender.
Reporting Event
Capital One reported its Q1 2026 profit.
Quarter Context
Events pertain to first quarter of 2026, recent as of current date.

Story Timeline

6 events
  1. 2026-04-21

    Capital One reports first-quarter 2026 profit missing estimates.

    1 source@business
  2. 2026-03-31

    End of first quarter 2026, during which Capital One set aside more cash for soured loans.

    1 sourceCapital One
  3. 2026-01-01

    Start of first quarter 2026, period for reported profit and loan provisions.

    1 source@business
  4. Pre-2026

    Capital One established as the biggest U.S. credit-card lender.

    1 sourceunattributed
  5. 2026 Q1

    Capital One increases cash reserves for soured loans.

    1 sourceCapital One
  6. 2026 Q1

    Profit reported for the quarter misses Wall Street estimates.

    1 sourceunattributed

Potential Impact

  1. 01

    Potential pressure on Capital One's stock price due to missed estimates.

  2. 02

    Possible adjustments in lending practices to mitigate soured loans.

  3. 03

    Increased scrutiny from investors on credit-card lending risks.

  4. 04

    Influence on Wall Street forecasts for upcoming quarters.

  5. 05

    Broader implications for U.S. banking sector loan quality assessments.

Transparency Panel

Sources cross-referenced1
Framing risk0/100 (low)
Confidence score65%
Synthesized bySubstrate AI
Word count62 words
PublishedApr 21, 2026, 8:46 PM
Bias signals removed4 across 4 outlets
Signal Breakdown
Loaded 3Amplifying 1

Related Stories

Oil Prices Drop After Reports of U.S.-Iran Talks on Ending War and Reopening Strait of HormuzJashuah / Wikimedia (CC BY-SA 3.0)
finance2 hrs ago

Oil Prices Drop After Reports of U.S.-Iran Talks on Ending War and Reopening Strait of Hormuz

Oil prices dropped significantly following reports that the U.S. and Iran are close to a memorandum of understanding to halt fighting and begin nuclear talks. President Trump announced a pause in the U.S. naval escort operation in the Strait of Hormuz. Iran is expected to respond…

cnbc.com
DE
UN
3 sources
Crypto Firm World Liberty Financial Sues Investor Justin Sun Over Alleged Smear Campaigninsidermonkey.com
finance2 hrs agoDeveloping

Crypto Firm World Liberty Financial Sues Investor Justin Sun Over Alleged Smear Campaign

World Liberty Financial, a cryptocurrency company founded by the Trump and Witkoff families, has filed a lawsuit accusing investor Justin Sun of conducting a smear campaign to harm its token's value. The suit claims Sun shorted the token in violation of agreements and used social…

Fox News
1 source
FDA Withdraws Studies Supporting Safety of COVID and Shingles VaccinesThe U.S. Food and Drug Administration / Wikimedia (Public domain)
finance2 hrs ago

FDA Withdraws Studies Supporting Safety of COVID and Shingles Vaccines

The U.S. Food and Drug Administration blocked the publication of research finding rare side effects from COVID and shingles vaccines. The studies were withdrawn due to broad conclusions not supported by data, amid broader efforts by the Trump administration to challenge vaccine r…

cnbc.com
The New York Times
Forbes
3 sources